Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy
ClinicalTrials.gov study NCT06384261. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Study of GDX012 in Patients With MRD Positive AML
ClinicalTrials.gov study NCT05001451. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04964518. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AML
ClinicalTrials.gov study NCT05662904. IPD Sharing: NO. Countries: 1. Publications: 0.
Avapritinib Maintenance for AML With KIT Mutations
ClinicalTrials.gov study NCT06765915. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ED-TBI Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory AML And Advanced MDS
ClinicalTrials.gov study NCT01709396. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Universal CAR-T Cells Targeting AML
ClinicalTrials.gov study NCT05995041. IPD Sharing: NO. Countries: 1. Publications: 0.
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
ClinicalTrials.gov study NCT04872478. IPD Sharing: NO. Countries: 1. Publications: 0.
Quality of Life-Guided Transfusion in Refractory MDS or AML
ClinicalTrials.gov study NCT07328191. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients
ClinicalTrials.gov study NCT04839341. IPD Sharing: NO. Countries: 1. Publications: 0.
Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML
ClinicalTrials.gov study NCT05805098. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients
ClinicalTrials.gov study NCT02550535. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AML
ClinicalTrials.gov study NCT07026942. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
CLL-1 CAR-NK Cells for Relapsed/Refractory AML
ClinicalTrials.gov study NCT06307054. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML
ClinicalTrials.gov study NCT00887042. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT
ClinicalTrials.gov study NCT03114670. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Donor-derived CAR-T Cells in the Treatment of AML Patients
ClinicalTrials.gov study NCT04766840. IPD Sharing: NO. Countries: 1. Publications: 0.
Dose-escalation of Siltuximab in Combination With Idarubicin and Cytarabine Chemotherapy in Patients With Acute Myeloblastic Leukaemia (AML) With Poor Prognosis: SILTUXILAM
ClinicalTrials.gov study NCT05697510. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms
ClinicalTrials.gov study NCT04637009. IPD Sharing: NO. Countries: 2. Publications: 0.
A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01305499. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.